1. [1] Dimenas, E.: Methodological aspects of evaluation of Quality of Life in upper gastr ointestinal diseases. Scand. J. Gastroenterol. Suppl., 199, 18-21, 1993.
2. [2] Orlando, R.C.: Esophageal epithelial resistance. in Gastroesophageal reflux disease: Pathogenesis, Diagnosis, Therapy, eds. By Castell, D.O., Wu, W.C., and Ott, D.J., Futura, Mount Kisco, pp. 55-79, 1985.
3. [3] Yoshida, N. and Yoshikawa, T.: Defense mechanism of the esophageal mucosa and esophageal inflammation. J. Gastroenterol., 38, 31-34, 2003.
4. [4] Yoshida, N., Uchiyama, K., Kuroda, M., Sakuma, K., Kokura, S., Ichikawa, H., Naito, Y., Takemura, T., Yoshikawa, T., and Okanoue, T.: IL-8 expression in the esophageal mucosa of patients with gastroesophageal reflux disease. Scand. J. Gastroenterol., 39, 816-822, 2004.
5. [5] Yoshida, N., Kuroda, M., Uchiyama, K., Suzuki, T., Okuda, T., Tsuboi, H., Kajikawa, H., Handa, O., Kokura, S., Ichikawa, H., Yoshikawa, T., and Okanoue, T.: Microarray analysis of transcriptome in patients with nonerosive reflux disease. Gastroenterology, 128, A-523, 2005.